Guo Xiaofei
Partner, Foreign Registered Lawyer
Telephone:
+65 6439 4892EMAIL:
xiaofei.guo@shooklin.comPractice Areas:
QUALIFICATION:
EDUCATIONS:
Languages:
Guo Xiaofei heads the Firm’s China Practice and she specialises in Capital Markets, M&A and foreign direct investment (FDI) in China. Since joining the Firm in 2009, she has been involved in a number of China-related IPOs, private and public takeovers in Singapore, FDIs in PRC and cross-border investments in Asia. She also advised high-net-worth PRC individuals on their family office and wealth planning.
Xiaofei is based in Singapore but travels regularly between Singapore and China advising clients on a wide range of matters, including Chinese clients’ overseas investments, financing and IPO structures, as well as Singapore and foreign clients’ investments, especially in the mining and energy, TMT, advertising, commercial and residential property, Build-To-Order (BTO) project and retail industries in China.
Prior to joining Shook Lin & Bok, Xiaofei worked on China-related M&A, FDI and IPO transactions in another Singapore law firm.
- Acted as Singapore counsel for Shanghai Sunmi Technology Co., Ltd. in connection with its initial public offering and listing on the Main Board of the Hong Kong Stock Exchange, raising approximately HK$1.06 billion (US$135 million) at an offer price of HK$97.5 per share, with strong investor demand and positive aftermarket performance;
- Advised Guangdong Haid Group Co., Limited, an A-share listed company, on its restructuring and spin-off and listing of Haid International Holdings Limited on the Stock Exchange of Hong Kong Limited;
- Advised Suzhou Dongshan Precision Manufacturing Co., Ltd, an A-share listed company, on its dual primary listing on the Stock Exchange of Hong Kong Limited;
- Advised Shanghai Sunmi Technology Co., Ltd on its initial public offering on the Stock Exchange of Hong Kong Limited;
- Advised Huazhu Group in its bond’s issuance and secondary listing on the Stock Exchange of Hong Kong Limited;
- Advised various PRC groups in their A-Share listings in mainland China, including but not limited BGI Genomics, Ningbo Sunrise, Novogene, Xiamen Xiangyu, Beijing E-Town Semiconductor, Ouyeel, Shanghai Sunmi Tech, Huaqin Tech and Mega Gravity Communication;
- Advised cryptocurrency mining firm Bitdeer Technologies going public on Nasdaq via a special purpose acquisition company (SPAC) merger with Blue Safari Group;
- Advised Centre Testing International Gorup on its 100% acquisition of Maritec Pte Ltd, and its acquisition of 90% shares of German engineering service provider imat-uve;
- Acted as lead counsel to a subsidiary of a PRC listco, Zhefu Holding Group in its US$161 million divestment in relation to an Indonesian hydro-power plant project;
- Acted as lead counsel to Linklogis, a supply chain fintech company, in their joint venture with, inter alios, Greenland Financial, in respect of the establishment of a digital banking business in Singapore;
- Advised Linklogis on the establishment of Olea, a Singapore-headquartered joint venture between Linklogis and Standard Chartered comprising a fully digitised trade finance origination and distribution platform;
- Acted for Tsingshan Holding Group Co, Ltd in the joint venture investment involving a subscription of 57% equity stake in Strand Minerals (Indonesia) Pte Ltd, a wholly owned subsidiary of Eramet SA, to develop the Weda Bay Nickel deposit in Indonesia;
- Advised one of the world’s largest communications groups, WPP Group on its various investments in e-commerce service business in China;
- Advised a PRC owner and operator of boutique hotels based in Singapore on his investments in hotel, industrial and residential properties in Singapore;
- Advised Sheng Siong Group Ltd on its joint venture investment in China;
- Advised AsiaPhos Limited on its further investment with its business partner in China;
- Advised Beijing Toread Outdoor Products Co Ltd, listed on the Shenzhen Stock Exchange, on its equity investment in Asiatravel.com Holdings Ltd, listed on Catalist of the Singapore Exchange;
- Advised AsiaPharm Holdings Ltd, the majority shareholder of Luye Pharmaceutical Investment Co., Ltd, on the acquisition of Luye Pharma Group Ltd through (1) the acquisition of all the interests held by Hygeia Holdings Ltd (wholly owned by MBK Partners, L.P.), and (2) the voluntary unconditional cash offer for all the issued and paid-up ordinary shares in the capital of Luye Pharma Group Ltd. The initial Hygeia acquisition represents a rare secondary buyout transaction in China. The acquiring consortium includes three of China’s largest private equity firms, being CDH Capital, CITIC Private Equity and New Horizon Capital;
- Advised AsiaPhos Limited, a Singapore-based phosphate resources company with mining and production operations based in the PRC, on its initial public offering on the Catalist board of the Singapore Exchange which raised S$30.5 million;
- Advised a private equity fund based in Singapore on its US$30 million joint venture in the education business in the PRC;
- Advised on the delistings of SGX-listed China Precision Technology Limited, Man Wah Holdings Limited and China Lifestyle Food and Beverages Group Ltd;
- Advised Sheng Siong Group Ltd, one of Singapore’s largest grocery retailers, on its initial public offering on the SGX-ST to raise S$63 million. This deal was awarded Best Small-Cap Equity Deal by FinanceAsia;
- Advised C&G Industrial Holdings Limited (the Company) on its acquisition of CUGU Environmental Protection International Limited and its waste-to-energy assets and businesses via the sale of the entire issued and paid-up capital of the Company, for an approximately RMB 500 million;
- Advised on the restructuring of SGX-listed Youcan Foods International Ltd and the divestment of its subsidiaries; and
- Advised SGX-listed Serial System Ltd on its proposed investment in SGX-listed JEL Corporation (Holdings) Ltd.